or Try an Advanced Search...

    Technical Analysis for ARVN - Arvinas, Inc.

    Grade Last Price % Change Price Change
    F 24.20 6.65% 1.51
    ARVN closed up 4.85 percent on Wednesday, November 20, 2024, on 1.26 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ARVN trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 6.65%
    Lower Bollinger Band Touch Weakness 6.65%
    Oversold Stochastic Weakness 6.65%
    180 Bearish Setup Bearish Swing Setup 11.83%
    Stochastic Buy Signal Bullish 11.83%
    Lower Bollinger Band Walk Weakness 11.83%
    Below Lower BB Weakness 11.83%
    Lower Bollinger Band Touch Weakness 11.83%
    Oversold Stochastic Weakness 11.83%
    Hammer Candlestick Bullish 4.36%
    Older End-of-Day Signals for ARVN ...

       Recent Intraday Alerts

    Alert Time
    Up 1 ATR 36 minutes ago
    Up 5% about 1 hour ago
    Up 3% about 2 hours ago
    60 Minute Opening Range Breakout about 2 hours ago
    Rose Above Previous Day's High about 3 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ARVN Chart by TradingView
    Basic chart:

    Profile

    Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Biology Disease Genetics Metabolism Chimera

    Is ARVN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 19 Arvinas, Inc. (ARVN): This Small-Cap Stock Is Ready To Explode
    Nov 19 Pfizer, Arvinas delay late-stage trial for breast cancer therapy
    Nov 4 Arvinas to Participate in Upcoming Investor Conferences
    Nov 1 Arvinas Third Quarter 2024 Earnings: Beats Expectations
    Oct 31 Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Promising ...
    Oct 30 Arvinas, Inc. (ARVN) Q3 2024 Earnings Call Transcript
    Oct 30 Arvinas, Inc. (ARVN) Reports Q3 Loss, Tops Revenue Estimates
    Oct 30 Arvinas GAAP EPS of -$0.68 beats by $0.13, revenue of $102.4M beats by $40M
    Oct 30 Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update
    Oct 29 Arvinas Q3 2024 Earnings Preview
    See more ARVN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 53.08
    52 Week Low 21.17
    Average Volume 592,035
    200-Day Moving Average 31.51
    50-Day Moving Average 25.62
    20-Day Moving Average 25.98
    10-Day Moving Average 24.95
    Average True Range 1.59
    RSI (14) 37.89
    ADX 22.23
    +DI 15.45
    -DI 31.66
    Chandelier Exit (Long, 3 ATRs) 24.84
    Chandelier Exit (Short, 3 ATRs) 25.94
    Upper Bollinger Bands 29.83
    Lower Bollinger Band 22.14
    Percent B (%b) 0.07
    BandWidth 29.62
    MACD Line -0.85
    MACD Signal Line -0.24
    MACD Histogram -0.6186
    Fundamentals Value
    Market Cap 1.25 Billion
    Num Shares 55 Million
    EPS -5.52
    Price-to-Earnings (P/E) Ratio -4.11
    Price-to-Sales 17.22
    Price-to-Book 6.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 25.00
    Resistance 3 (R3) 24.75 23.73 24.62
    Resistance 2 (R2) 23.73 23.14 23.86 24.49
    Resistance 1 (R1) 23.21 22.78 23.47 23.46 24.36
    Pivot Point 22.19 22.19 22.32 22.32 22.19
    Support 1 (S1) 21.67 21.60 21.93 21.92 21.02
    Support 2 (S2) 20.65 21.24 20.78 20.89
    Support 3 (S3) 20.13 20.65 20.77
    Support 4 (S4) 20.38